TheraRadar
← Back
Data updated: Jun 28, 2026

JAVELIN PHARMS INC

Pharma
Pharmaceuticals

JAVELIN PHARMS INC is a pharmaceutical company with 1 FDA-approved products.

2014
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

Upcoming FDA Decisions

Full Calendar →
Jan 20, 2027 — Foundayo (orforglipron)

JAVELIN PHARMS INC's Key Drugs

JAVELIN PHARMS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

JAVELIN PHARMS INC's Recent FDA Approvals

New NDA/BLA approvals for JAVELIN PHARMS INC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

JAVELIN PHARMS INC's Therapeutic Areas

Disease areas where JAVELIN PHARMS INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

JAVELIN PHARMS INC Pipeline Snapshot

Active clinical trials for JAVELIN PHARMS INC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling